세계의 마이크로니들 시장 예측(-2030년)

Market Outline

The Microneedling Market size is projected to enlist a sound CAGR of 10.31% during the conjecture time frame. The expansion is popular for negligibly obtrusive strategies, the ascent in the use of microneedling, and the developing clinical travel industry are driving market development.

Interest in insignificantly and harmless skin revival and body shaping methodology utilizing novel radiofrequency frameworks is developing at a fast speed. These insignificantly and harmless advancements have turned into the quickest developing areas of tasteful medication. Microneedling is an insignificantly obtrusive, non-ablative procedure ordinarily utilized for body molding, skin fixing, and cellulite decrease.

The greatest advantage of clinical travel is the expense of reserve funds since offices in immature countries can charge less due to the country's financial circumstances. In lacking nations, there is a lower GDP (Gross domestic product) per capita, which means lower wages. Moreover, costs for operations and medicines are far lower than in well-off nations.

Market Segmentation

The Market segments of Microneedling, based on procedure, include RF microneedling, traditional microneedling, and PRP microneedling. The product segment includes derma-stamp, dermapen, dermarollers, RF microneedling devices, and others.

Based on needle material the market is divided into silicon, metal, glass, and others. The Market segmentation of Microneedling is based on an application that includes, skin rejuvenation, acne scars, traumatic & surgical scars, and others. The end-user segment includes hospitals, dermatology clinics, home care settings, and others.

Regional Insights

The North American microneedling market represented the biggest market share in 2022. This is because of the rising occurrence of alopecia and different dermatological sicknesses and the presence of cutting-edge medical care offices and gifted experts in the region, and the rising vital association and expanding speculation by central parts in the region.

Europe microneedling market represents the second-biggest market share because of the developing help by government bodies for the utilization of negligibly obtrusive techniques, the rising number of item endorsements and the accessibility of items across the region, and the developing prevalence of insignificantly obtrusive innovation in the region.

The Asia-Pacific microneedling market is supposed to develop at a huge offer from 2023 to 2030. This is because of the expansion in the interest in antiaging treatment, the ascent in the way of life, and the development Research and development exercises in surgeries in the Asia-Pacific region.

Moreover, the developing buyer extra cash levels in arising nations and developing mechanical advancement are probably going to have extensive market development for microneedling.

The rest of the World is portioned into the Center East, Africa, and Latin America. The market for microneedling in the previously mentioned regions is probably going to observe development because of the rising commonness of negligibly obtrusive methodology and the rising stylish awareness among purchasers in these regions.

Major Players

Key Companies in the market of Microneedling include Crown Aesthetics (US), Lumenis Be Ltd (Israel), Aesthetics Biomedical (US), INMODE (US), LUTRONIC (US), Cynosure (US), Cutera (US), Endymed (US), Candela Corporation (US), and Dermaroller GmbH (Germany).

TABLE OF CONTENTS

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

• 2.1. DEFINITION
• 2.2. SCOPE OF THE STUDY
  • 2.2.1. RESEARCH OBJECTIVE
  • 2.2.2. ASSUMPTIONS
  • 2.2.3. LIMITATIONS

3. RESEARCH METHODOLOGY

• 3.1. OVERVIEW
• 3.2. DATA MINING
• 3.3. SECONDARY RESEARCH
• 3.4. PRIMARY RESEARCH
  • 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5. FORECASTING MODALITY
• 3.6. MARKET SIZE ESTIMATION
  • 3.6.1. BOTTOM-UP APPROACH
  • 3.6.2. TOP-DOWN APPROACH
• 3.7. DATA TRIANGULATION
• 3.8. VALIDATION

4. MARKET DYNAMICS

• 4.1. OVERVIEW
• 4.2. DRIVERS
• 4.3. RESTRAINTS
• 4.4. OPPORTUNITIES

5. MARKET FACTOR ANALYSIS

• 5.1. VALUE CHAIN ANALYSIS
• 5.2. PORTER'S FIVE FORCES ANALYSIS
  • 5.2.1. BARGAINING POWER OF SUPPLIERS
  • 5.2.2. BARGAINING POWER OF BUYERS
  • 5.2.3. THREAT OF NEW ENTRANTS
  • 5.2.4. THREAT OF SUBSTITUTES
  • 5.2.5. INTENSITY OF RIVALRY
• 5.3. COVID-19 IMPACT ANALYSIS
  • 5.3.1. IMPACT ON DEMAND
  • 5.3.2. IMPACT ON PRICING
  • 5.3.3. IMPACT ON KEY PLAYERS

6. GLOBAL MICRONEEDLING MARKET, BY PROCEDURE

• 6.1. OVERVIEW
• 6.2. RF MICRONEEDLING
• 6.3. TRADITIONAL MICRONEEDLING
• 6.4. PRP MICRONEEDLING

7. GLOBAL MICRONEEDLING MARKET, BY PRODUCT

• 7.1. OVERVIEW
• 7.2. DERMA-STAMP
• 7.3. DERMAPEN
• 7.4. DERMAROLLERS
• 7.5. RF MICRONEEDLING DEVICES
• 7.6. OTHERS

8. GLOBAL MICRONEEDLING MARKET, BY NEEDLE MATERIAL

• 8.1. OVERVIEW
• 8.2. SILICON
• 8.3. METAL
• 8.4. GLASS
• 8.5. OTHERS

9. GLOBAL MICRONEEDLING MARKET, BY APPLICATION

• 9.1. OVERVIEW
• 9.2. SKIN REJUVENATION
• 9.3. ACNE SCARS
• 9.4. TRAUMATIC & SURGICAL SCARS
• 9.5. OTHERS

10. GLOBAL MICRONEEDLING MARKET, BY END USER

• 10.1. OVERVIEW
• 10.2. HOSPITALS
• 10.3. DERMATOLOGY CLINICS
• 10.4. HOMECARE SETTINGS
• 10.5. OTHERS

11. GLOBAL MICRONEEDLING MARKET, BY REGION

• 11.1. OVERVIEW
• 11.1. NORTH AMERICA
  • 11.1.1. US
  • 11.1.2. CANADA
• 11.2. EUROPE
  • 11.2.1. GERMANY
  • 11.2.2. FRANCE
  • 11.2.3. UK
  • 11.2.4. ITALY
  • 11.2.5. SPAIN
  • 11.2.6. REST OF EUROPE
• 11.3. ASIA-PACIFIC
  • 11.3.1. CHINA
  • 11.3.2. INDIA
  • 11.3.3. JAPAN
  • 11.3.4. SOUTH KOREA
  • 11.3.5. AUSTRALIA
  • 11.3.6. REST OF ASIA-PACIFIC
• 11.4. REST OF THE WORLD
  • 11.4.1. MIDDLE EAST
  • 11.4.2. AFRICA
  • 11.4.3. LATIN AMERICA

12. COMPETITIVE LANDSCAPE

• 12.1. OVERVIEW
• 12.2. COMPETITIVE ANALYSIS
• 12.3. MARKET SHARE ANALYSIS
• 12.4. MAJOR GROWTH STRATEGY IN THE GLOBAL MICRONEEDLING MARKET,
• 12.5. COMPETITIVE BENCHMARKING
• 12.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MICRONEEDLING MARKET,
• 12.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
  • 12.7.1. NEW PRODUCT LAUNCH/SERVICE DEPLOYMENT
  • 12.7.2. MERGER & ACQUISITIONS
  • 12.7.3. JOINT VENTURES
• 12.8. MAJOR PLAYERS FINANCIAL MATRIX
  • 12.8.1. SALES & OPERATING INCOME, 2022
  • 12.8.2. MAJOR PLAYERS R&D EXPENDITURE. 2022

13. COMPANY PROFILES

• 13.1. CROWN AESTHETICS
  • 13.1.1. COMPANY OVERVIEW
  • 13.1.2. FINANCIAL OVERVIEW
  • 13.1.3. PRODUCTS OFFERED
  • 13.1.4. KEY DEVELOPMENTS
  • 13.1.5. SWOT ANALYSIS
  • 13.1.6. KEY STRATEGIES
• 13.2. LUMENIS BE LTD
  • 13.2.1. COMPANY OVERVIEW
  • 13.2.2. FINANCIAL OVERVIEW
  • 13.2.3. PRODUCTS OFFERED
  • 13.2.4. KEY DEVELOPMENTS
  • 13.2.5. SWOT ANALYSIS
  • 13.2.6. KEY STRATEGIES
• 13.3. AESTHETICS BIOMEDICAL
  • 13.3.1. COMPANY OVERVIEW
  • 13.3.2. FINANCIAL OVERVIEW
  • 13.3.3. PRODUCTS OFFERED
  • 13.3.4. KEY DEVELOPMENTS
  • 13.3.5. SWOT ANALYSIS
  • 13.3.6. KEY STRATEGIES
• 13.4. INMODE
  • 13.4.1. COMPANY OVERVIEW
  • 13.4.2. FINANCIAL OVERVIEW
  • 13.4.3. PRODUCTS OFFERED
  • 13.4.4. KEY DEVELOPMENTS
  • 13.4.5. SWOT ANALYSIS
  • 13.4.6. KEY STRATEGIES
• 13.5. LUTRONIC
  • 13.5.1. COMPANY OVERVIEW
  • 13.5.2. FINANCIAL OVERVIEW
  • 13.5.3. PRODUCTS OFFERED
  • 13.5.4. KEY DEVELOPMENTS
  • 13.5.5. SWOT ANALYSIS
  • 13.5.6. KEY STRATEGIES
• 13.6. CYNOSURE
  • 13.6.1. COMPANY OVERVIEW
  • 13.6.2. FINANCIAL OVERVIEW
  • 13.6.3. PRODUCTS OFFERED
  • 13.6.4. KEY DEVELOPMENTS
  • 13.6.5. SWOT ANALYSIS
  • 13.6.6. KEY STRATEGIES
• 13.7. CUTERA
  • 13.7.1. COMPANY OVERVIEW
  • 13.7.2. FINANCIAL OVERVIEW
  • 13.7.3. PRODUCTS OFFERED
  • 13.7.4. KEY DEVELOPMENTS
  • 13.7.5. SWOT ANALYSIS
  • 13.7.6. KEY STRATEGIES
• 13.8. ENDYMED
  • 13.8.1. COMPANY OVERVIEW
  • 13.8.2. FINANCIAL OVERVIEW
  • 13.8.3. PRODUCTS OFFERED
  • 13.8.4. KEY DEVELOPMENTS
  • 13.8.5. SWOT ANALYSIS
  • 13.8.6. KEY STRATEGIES
• 13.9. CANDELA CORPORATION
  • 13.9.1. COMPANY OVERVIEW
  • 13.9.2. FINANCIAL OVERVIEW
  • 13.9.3. PRODUCTS OFFERED
  • 13.9.4. KEY DEVELOPMENTS
  • 13.9.5. SWOT ANALYSIS
  • 13.9.6. KEY STRATEGIES
• 13.10. DERMAROLLER GMBH
  • 13.10.1. COMPANY OVERVIEW
  • 13.10.2. FINANCIAL OVERVIEW
  • 13.10.3. PRODUCTS OFFERED
  • 13.10.4. KEY DEVELOPMENTS
  • 13.10.5. SWOT ANALYSIS
  • 13.10.6. KEY STRATEGIES

14. APPENDIX

• 14.1. REFERENCES
• 14.2. RELATED REPORTS